Mark serves as chairman and chief executive of Tourmaline Holdings and founded Animal Health Angels. He brings board advisory experience across multiple ventures.
Wendy is a veterinary surgeon and conservationist who co-founded Animal Health Angels. She serves as a trustee for the Painted Wolf Foundation and holds advisory roles at Nottingham University Business School.
THENA Capital led the seed round to help advance Zonova toward major OEM partnerships and international deployment.
"This funding marks a defining moment for Zonova. We founded the company with the belief that infection prevention in medical devices needed a fundamentally new approach, one that moves beyond coatings, antibiotics, and short term fixes. Our technology has the potential to redefine how medical devices are designed globally by embedding antimicrobial protection directly into the material itself. THENA Capital immediately understood both the scale of the clinical problem and the magnitude of the commercial opportunity. The THENA team brings an exceptional combination of scientific depth, strategic insight, and operational ambition that is incredibly rare in venture. We are thrilled to have them leading this round and joining us as we scale toward major OEM partnerships and international deployment."
The seed round was led by EMV Capital and includes participation from Animal Health Angels.
"SageTech Medical’s mission aligns perfectly with our vision of fostering groundbreaking innovations that benefit the wider animal health ecosystem. Their commitment to sustainability and environmental stewardship is inspiring, and we are thrilled to play a role in their growth journey."
NovaQuest led the financing round, which drew participation from eight investors across three continents.
"Following on from our successful seed funding round from Gabriel Investments and Equity Gap, Series A is an important milestone in our global growth plans, as we seek to improve health outcomes for animals through earlier disease diagnosis using revolutionary biomarker technology and artificial intelligence. The geographical spread of this investment round reflects the global opportunity for MI:RNA to deploy our platform for better outcomes for pets."
The funding round was led by JamJar Investments, with backing from Active Partners and Animal Health Angels.
"Marleybones is driven by our founding mission of making dogs healthier and happier. This investment will allow us to continue delivering on that promise and caring for more dogs than ever before. Having seen the benefits on my own dog Marley, and the customers we’re lucky enough to serve, we’re excited about what this investment unlocks for our community"
